SPATS2 and hepatocellular carcinoma: SPATS2 is significant upregulated in HCC cells transfected with MiR-145-5p-mimics, while reverse changes of SPATS2 were observed in HCC cells transfected with MiR-145-5p-inhibitor (Fig. 6j).